- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05401266
The Effect of Mild Hypercapnia During Anesthetic Emergence on Recovery Time From TIVA
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At present, there is no effective intervention method for the recovery of general anesthesia, and the elimination of anesthetic agents, especially from the brain is a decisive factor in the emergence from general anesthesia. Many studies have reported the effect of hypercapnia on recovery time from volatile anesthetics. Hypercapnia can increase cardiac output and cerebral blood flow, increasing the ability to remove volatile anesthetics from the brain and shortening the recovery time from anesthesia.
Propofol is becoming the most common intravenous agent used for induction as well as maintenance of total intravenous anesthesia (TIVA). Its rapid elimination from the blood and brain is expected to shorten the recovery time from TIVA. Only a few clinical studies have investigated the relationship between hypercapnia and emergence time with propofol anesthesia. But those studies may have been influenced by postoperative pain, so the recovery time cannot reflect propofol metabolism alone. Moreover, intraoperative hypercapnia may increase the need for intraoperative anesthetic agents by increasing the clearance of agents from the brain.
As a non-invasive method, Transcranial Doppler ultrasonography(TCD)can be used to monitor blood flow changes in different parts of cerebral arterial circle(Willis circle), and its safety and effectiveness in perioperative related fields have been proved.
We hypothesized that patients with mild hypercapnia during anesthetic emergence after TIVA had a shorter recovery time than patients with normal blood carbonate levels. We will select patients undergoing transurethral lithotripsy, who were expected to have mild postoperative pain, compare tracheal extubation time in patients with normal blood carbonic acid level and mild hypercapnia, to evaluate the effect of blood carbonic acid level during anesthetic emergence on recovery time from TIVA by. We also examined the changes of cerebral blood flow by TCD to investigate the possible mechanism of mild hypercapnia affecting the recovery time from TIVA.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lan Liu, Master
- Phone Number: +86 13958033523
- Email: zrll@zju.edu.cn
Study Contact Backup
- Name: Li Na Yu, Professor
- Phone Number: +86 13958033387
- Email: zryulina@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310009
- Recruiting
- 2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
-
Contact:
- Lan Liu, Master
- Phone Number: +86 13958033523
- Email: zrll@zju.edu.cn
-
Contact:
- Li Na Yu, PhD
- Phone Number: +86 13958033387
- Email: zryulina@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients aged 20-60 years, with American Society of Anesthesiology physical status 1 to 2, undergoing transurethral lithotripsy under TIVA with endotracheal intubation; voluntarily signed informed consent forms.
Exclusion Criteria:
- Patients with mental, pulmonary, cardiac, endocrine, neuromuscular, liver and nervous system diseases or a history of such diseases; Lung CT showed atelectasis, pulmonary infection and pleural effusion. Patients taking sedatives or other drugs that might interfere with the study; Alcohol or drug dependence; Patients who have had a history of general anesthesia within the past month; Patients with body mass index (BMI) of 30 kg/m2 or above; Patients who are expected to be under anesthesia for less than 30 minutes; Patients with difficult airways.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: normal blood carbonic acid level
After propofol infusion was stopped, ventilation parameters were adjusted to maintain end-expiratory carbon dioxide (ETCO2) 35-40 mmHg until spontaneous respiration was restored.
|
|
EXPERIMENTAL: mild hypercapnia
After propofol infusion was stopped, ventilation parameters were adjusted to achieve and maintain ETCO2 50-55 mmHg until spontaneous respiration was restored.
|
Ventilation parameters were adjusted to achieve and maintain ETCO2 50-55 mmHg until spontaneous respiration was restored
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tracheal extubation time
Time Frame: 1 year
|
The time from propofol infusion stopped to Tracheal extubation
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time of anesthesia
Time Frame: 1 year
|
Time from anesthesia induction to cessation of propofol infusion
|
1 year
|
Total infusion of propofol and remifentanil
Time Frame: 1 year
|
Total infusion of propofol and remifentanil
|
1 year
|
Spontaneous respiratory recovery time
Time Frame: 1 year
|
The time from the beginning of cessation of propofol infusion to the time when the patient begins to cough or when the ETCO2 waveform changes
|
1 year
|
Time of eyes or mouth opening
Time Frame: 1 year
|
The time from the beginning of cessation of propofol infusion to the time when patients can open their eyes or mouth
|
1 year
|
Changes in cerebral blood flow examined by transcranial Doppler (TCD)
Time Frame: 1 year
|
Examine at the following four time points: before anesthesia induction; 10min after operation; After adjustment of ETCO2 is completed in post-anaesthesia care unit(PACU); 20 min after tracheal extubation
|
1 year
|
Collaborators and Investigators
Investigators
- Study Director: Li Li Fang, PhD, Study Official Affiliation
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0389
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Intravenous Anesthesia
-
Bozyaka Training and Research HospitalRecruitingAnesthesia | Total Intravenous AnesthesiaTurkey
-
Samsung Medical CenterUnknownGeneral Anesthesia | Total Intravenous Anesthesia | Bispectral Index MonitoringKorea, Republic of
-
Assiut UniversityRecruitingTotal Intravenous Anesthesia | Inhalational Anesthesia | Surgical Stress Response | Target-controlled InfusionEgypt
-
Bezmialem Vakif UniversityCompletedPropofol | Remifentanil | Total Intravenous Anesthesia | Bispectral Index Monitoring
-
Tanta UniversityCompleted
-
Hospices Civils de LyonUnknownInduction of Total Intravenous General AnesthesiaFrance
-
National Taiwan University HospitalCompletedLung Diseases | Tracheal Diseases | Total Intravenous AnesthesiaTaiwan
-
Universidad de AntioquiaCompletedAnesthesia, General | Anesthesia, IntravenousColombia
-
University of Erlangen-Nürnberg Medical SchoolCompletedAnesthesia | Anesthesia, IntravenousGermany
-
Seoul National University HospitalHana Pharm Co., Ltd.CompletedAnesthesia, IntravenousKorea, Republic of
Clinical Trials on mild hypercapnia
-
Australian and New Zealand Intensive Care Research...National Health and Medical Research Council, Australia; Health Research Board...Active, not recruitingOut-Of-Hospital Cardiac ArrestAustralia, United Kingdom, Italy, Finland, Denmark, Ireland, New Zealand, Belgium, Slovenia, France, Netherlands, Norway, Saudi Arabia, Sweden
-
Walid HABRECompleted
-
VA Office of Research and DevelopmentDetroit VARecruitingSleep Apnea | Hypercapnia | SCI/DUnited States
-
University of WuerzburgCompleted
-
Cairo UniversityCompleted
-
University Hospital, Strasbourg, FranceCompletedHypercapnia | Pulmonary Vascular Sensibility in Hypoxia | Hypoxia and HypercapniaFrance
-
Great Ormond Street Hospital for Children NHS Foundation...CompletedCongenital Diaphragmatic Hernia | Esophageal Atresia With Tracheo-esophageal FistulaUnited Kingdom
-
Baylor College of MedicineNational Institute of Neurological Disorders and Stroke (NINDS)TerminatedIntraventricular Hemorrhage | AutoregulationUnited States
-
University of Alabama at BirminghamCompletedPremature NeonateUnited States
-
Gachon University Gil Medical CenterCompletedCerebral Ischemia